Effects of repeated amphetamine treatment on the locomotor activity of the dopamine D(1A)-deficient mouse

NeuroReport

Volumn 8, Issue 11, 1997, Pages 2523-2527

  Crawford, Cynthia A ^a,b   Drago, John ^c   Watson, Joseph B ^a   Levine, Michael S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CALIFORNIA STATE UNIVERSITY   (United States)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Amphetamine; Behavioral sensitization; Dopamine receptor; Protein kinase A

Indexed keywords

AMPHETAMINE; CYCLIC AMP DEPENDENT PROTEIN KINASE; DOPAMINE 1 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVITY; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION;

EID: 0030852689     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199707280-00021     Document Type: Article

References (25)

1. Kalivas PW and Stewart J. Brain Res Rev 16, 223-244 (1991).
2. Robinson TE and Becker JB. Brain Res Rev 11, 157-198 (1986).
3. Wolf ME, White FJ and Hu XT. J Neurosci 14, 1735-1745 (1994).
4. Cooper JR, Bloom FE and Roth RH. Biochemical Basis of Neuropharmacology, 7th edn. New York: Oxford Unoversity Press, 1996.
5. Hamamura T, Akiyama K, Akimoto K et al. Brain Res 546, 40-46 (1991).
6. Henry DJ and White FJ. J Pharmacol Exp Ther 258, 882-890 (1991).
7. Mattingly BA, Rowlett JK, Graff JT et al. Psychopharmacology 105, 501-507 (1991).
8. Mayfield RD, Larson G and Zahniser NR. Brain Res 573, 331-335 (1992).
9. Vezina P. J Neurosci 16, 2411-2420 (1996).
10. Wolf ME, Dahlin SL, Hu XT et al. Neuroscience 69, 417-439 (1996).
11. Kalivas PW and Duffy P. J Neurosci 13, 266-275 (1993).
12. Robinson, TE, Jurson PA, Bennett JA et al. Brain Res 462, 211-222 (1988).
13. Mindy JD and Nestler EJ. Brain Res 674, 299-306 (1995).
14. Roseboom PH, Hewlett GH and Gnegy ME. J Pharmacol Exp Ther 255, 197-203 (1990).
15. Steketee JD. NeuroReport 6, 69-72 (1994).
16. Striplin CD and Kalivas PW. Brain Res 579, 181-186 (1992).
17. Drago J, Gerfen CR, Lachowicz JE et al. Proc Natl Acad Sci USA 91, 12564-12568 (1994).
18. Miner LL, Drago J, Chamberlain PM et al. NeuroReport 6, 2314-2316 (1995).
19. Xu M, Hu X, Cooper DC et al. Cell 79, 945-955 (1994).
20. Levine MS, Altemus KL, Cepeda C et al. J Neurosci 15, 5870-5882 (1996).
21. Bradford MM. Anal Biochem 72, 248-255 (1976).
22. Nestler EJ and Tallman JF. Mol Pharmacol 33, 127-132 (1988).
23. Pauly JR. Robinson SF and Collins AC. Brain Res 620, 195-202 (1993).
24. Giros B, Jaber M, Jones SR et al. Nature 379, 606-612 (1996).
25. Cador M, Bijijou Y and Stinus L. Neuroscience 65, 385-395 (1995).